{
"html_url": "https://licitia.com.mx/adjudicacion/aa-12-nef-012nef001-i-6-2026",
"canonical": "https://licitia.com.mx/adjudicacion/aa-12-nef-012nef001-i-6-2026",
"id": "c64a724f9b2347c6a37f91bfc055e86d",
"procedure_number": "AA-12-NEF-012NEF001-I-6-2026",
"file_number": "E-2026-00000071",
"title": "COMPRA CONSOLIDADA DE MEDICAMENTOS PATENTE Y FUENTE ÚNICA: TERCER PROCEDIMIENTO",
"description": {
"short": "No existen bienes alternativos o sustitutos, Único Oferente, Derechos exclusivos (patentes, licencias, derechos de autor u otros derechos exclusivos), o por obras de arte.",
"detailed": "COMPRA CONSOLIDADA DE MEDICAMENTOS PATENTE Y FUENTE ÚNICA: TERCER PROCEDIMIENTO"
},
"lifecycle": {
"section": "concluido",
"source_status": "ADJUDICADO",
"moved_at": null
},
"buyer": {
"agency": "LABORATORIOS DE BIOLÓGICOS Y REACTIVOS DE MÉXICO, S.A. DE C.V.",
"acronym": "BIRMEX",
"branch": "12 - SALUD",
"buying_unit": "DIRECCIÓN DE ADMINISTRACIÓN Y FINANZAS",
"requesting_unit": "unidad requiriente data",
"requesting_group": "DIRECCIÓN DE ADMINISTRACIÓN Y FINANZAS",
"entity": "TESORERÍA DE LA FEDERACIÓN",
"slug": "birmex",
"unit_slug": "direccion-de-administracion-y-finanzas-012nef001"
},
"classification": {
"procedure_type": "ADJUDICACIÓN DIRECTA",
"contracting_type": "ADQUISICIONES",
"publication_type": null,
"character": "INTERNACIONAL ABIERTO",
"fiscal_year": 2026,
"law": "LEY DE ADQUISICIONES, ARRENDAMIENTOS Y SERVICIOS DEL SECTOR PÚBLICO",
"legal_basis_id": "246",
"exception_basis": "Art. 54 fr. I",
"internal_control_number": "BIRMEX-ADCC-01-2026",
"supply_source_number": null
},
"schedule": {
"published_at": "2026-01-03T00:34:15.000Z",
"clarification_meeting_at": null,
"clarification_questions_deadline_at": null,
"clarification_responses_deadline_at": null,
"bid_opening_at": null,
"award_at": null,
"estimated_contract_at": "2026-01-30T06:00:00.000Z",
"site_visit_at": null,
"estimated_work_start_at": null
},
"estimated_value": {
"minimum": null,
"maximum": null,
"currency": "MXN",
"updated_at": null
},
"lots": [
{
"number": "1",
"name": "PARTIDA SOLA",
"description": "PARTIDA SOLA",
"requirement_group_id": "1",
"items": [
{
"number": "1",
"cucop_code": "25301-2613",
"specific_item_code": "25301",
"cucop_description": "010.000.5643.00 FACTOR VIII DE LA COAGULACION SANGUINEA HUMANO/FACTOR DE VON WILLEBRAND SOLUCION INYECTABLE 250 UI/600 UI ENVASE CON UN FRASCO AMPULA CON LIOFILIZADO Y UN FRASCO AMPULA CON 5 ML DE DILUYENTE",
"description": "FACTOR VIII DE LA COAGULACIÓN SANGUÍNEA HUMANO/FACTOR DE VON WILLEBRAND. SOLUCIÓN INYECTABLE. CADA FRASCO ÁMPULA CON LIOFILIZADO CONTIENE: FACTOR VIII DE LA COAGULACIÓN SANGUÍNEA HUMANO 250 UI. FACTOR DE VON WILLEBRAND 600 UI. ENVASE CON UN FRASCO ÁMPULA CON LIOFILIZADO Y UN FRASCO ÁMPULA CON 5 ML DE DILUYENTE.",
"requested_quantity": "677",
"minimum_quantity": "677",
"maximum_quantity": "1690",
"unit": "PIEZA",
"minimum_amount": null,
"maximum_amount": null
},
{
"number": "2",
"cucop_code": "25301-2614",
"specific_item_code": "25301",
"cucop_description": "010.000.5644.00 FACTOR VIII DE LA COAGULACION SANGUINEA HUMANO/FACTOR DE VON WILLEBRAND SOLUCION INYECTABLE 500 UI/1200 UI ENVASE CON UN FRASCO AMPULA CON LIOFILIZADO Y UN FRASCO AMPULA CON 10 ML DE DILUYENTE",
"description": "FACTOR VIII DE LA COAGULACIÓN SANGUÍNEA HUMANO/FACTOR DE VON WILLEBRAND. SOLUCIÓN INYECTABLE. CADA FRASCO ÁMPULA CON LIOFILIZADO CONTIENE: FACTOR VIII DE LA COAGULACIÓN SANGUÍNEA HUMANO 500 UI. FACTOR DE VON WILLEBRAND 1200 UI. ENVASE CON UN FRASCO ÁMPULA CON LIOFILIZADO Y UN FRASCO ÁMPULA CON 10 ML DE DILUYENTE.",
"requested_quantity": "80",
"minimum_quantity": "80",
"maximum_quantity": "199",
"unit": "PIEZA",
"minimum_amount": null,
"maximum_amount": null
},
{
"number": "3",
"cucop_code": "25301-2717",
"specific_item_code": "25301",
"cucop_description": "010.000.6055.00 INHIBIDOR DE LA ESTERASA C1 HUMANO SOLUCION INYECTABLE 500 UI ENVASE CON FRASCO AMPULA CON LIOFILIZADO Y FRASCO AMPULA CON 10 ML DE DILUYENTE",
"description": "INHIBIDOR DE LA ESTERASA C1 HUMANO. SOLUCIÓN INYECTABLE. CADA FRASCO ÁMPULA CONTIENE: INHIBIDOR DE LA ESTERASA C1 HUMANO 500 UI. ENVASE CON FRASCO ÁMPULA CON LIOFILIZADO Y FRASCO ÁMPULA CON 10 ML DE DILUYENTE.",
"requested_quantity": "415",
"minimum_quantity": "415",
"maximum_quantity": "1037",
"unit": "PIEZA",
"minimum_amount": null,
"maximum_amount": null
}
]
}
],
"awards": [
{
"id": "C-2026-00001926",
"internal_reference": "HGMEL-AD-CC-030-2026",
"title": "COMPRA CONSOLIDADA DE MEDICAMENTOS PATENTE Y FUENTE ÚNICA: TERCER PROCEDIMIENTO",
"status": "CONFIRMADA",
"contractor": {
"name": "CSL BEHRING SA DE CV",
"normalized_name": "CSL BEHRING",
"rfc_type": null,
"slug": "csl-behring"
},
"contract_period": {
"published_at": "2026-01-08T23:39:14.000Z",
"starts_at": "2026-01-07T06:00:00.000Z",
"ends_at": "2026-12-31T06:00:00.000Z"
},
"value": {
"subtotal": "670235.68",
"tax": "0",
"total": "670235.68",
"maximum_subtotal": "1665693.98",
"maximum_total": "1665693.98",
"currency": "MXN"
},
"open_contract_type": null,
"quantity": null,
"exercised_quantity": null,
"participants": [],
"line_items": [
{
"number": "0",
"cucop_code": "25301-2614",
"description": "010.000.5644.00 FACTOR VIII DE LA COAGULACION SANGUINEA HUMANO/FACTOR DE VON WILLEBRAND SOLUCION INYECTABLE 500 UI/1200 UI ENVASE CON UN FRASCO AMPULA CON LIOFILIZADO Y UN FRASCO AMPULA CON 10 ML DE DILUYENTE",
"unit": "PIEZA",
"requested_quantity": "80",
"awarded_quantity": null,
"unit_price": "3151.78",
"subtotal": "252142.4",
"tax": "1968",
"other_taxes": null,
"total": "252142.4"
},
{
"number": "0",
"cucop_code": "25301-2717",
"description": "010.000.6055.00 INHIBIDOR DE LA ESTERASA C1 HUMANO SOLUCION INYECTABLE 500 UI ENVASE CON FRASCO AMPULA CON LIOFILIZADO Y FRASCO AMPULA CON 10 ML DE DILUYENTE",
"unit": "PIEZA",
"requested_quantity": "31",
"awarded_quantity": null,
"unit_price": "13486.88",
"subtotal": "418093.28",
"tax": "86.97",
"other_taxes": null,
"total": "418093.28"
}
]
},
{
"id": "C-2026-00005823",
"internal_reference": "RM-AF-0375/26",
"title": "RM-AF-0375/26",
"status": "CONFIRMADA",
"contractor": {
"name": "CSL BEHRING SA DE CV",
"normalized_name": "CSL BEHRING",
"rfc_type": null,
"slug": "csl-behring"
},
"contract_period": {
"published_at": "2026-01-22T18:09:14.000Z",
"starts_at": "2026-01-06T06:00:00.000Z",
"ends_at": "2026-12-31T06:00:00.000Z"
},
"value": {
"subtotal": "386093.05",
"tax": "0",
"total": "386093.05",
"maximum_subtotal": "964444.68",
"maximum_total": "964444.68",
"currency": "MXN"
},
"open_contract_type": null,
"quantity": null,
"exercised_quantity": null,
"participants": [],
"line_items": [
{
"number": "0",
"cucop_code": "25301-2613",
"description": "010.000.5643.00 FACTOR VIII DE LA COAGULACION SANGUINEA HUMANO/FACTOR DE VON WILLEBRAND SOLUCION INYECTABLE 250 UI/600 UI ENVASE CON UN FRASCO AMPULA CON LIOFILIZADO Y UN FRASCO AMPULA CON 5 ML DE DILUYENTE",
"unit": "PIEZA",
"requested_quantity": "245",
"awarded_quantity": null,
"unit_price": "1575.89",
"subtotal": "386093.05",
"tax": "1344",
"other_taxes": null,
"total": "386093.05"
}
]
},
{
"id": "C-2026-00003944",
"internal_reference": "IB/BMX/0040/2026",
"title": "COMPRA CONSOLIDADA DE MEDICAMENTOS PATENTE Y FUENTE ÚNICA: TERCER PROCEDIMIENTO",
"status": "CONFIRMADA",
"contractor": {
"name": "CSL BEHRING SA DE CV",
"normalized_name": "CSL BEHRING",
"rfc_type": null,
"slug": "csl-behring"
},
"contract_period": {
"published_at": "2026-01-15T20:31:52.000Z",
"starts_at": "2026-01-03T06:00:00.000Z",
"ends_at": "2026-12-31T06:00:00.000Z"
},
"value": {
"subtotal": "680784.48",
"tax": "0",
"total": "680784.48",
"maximum_subtotal": "1698809.42",
"maximum_total": "1698809.42",
"currency": "MXN"
},
"open_contract_type": null,
"quantity": null,
"exercised_quantity": null,
"participants": [],
"line_items": [
{
"number": "0",
"cucop_code": "25301-2613",
"description": "010.000.5643.00 FACTOR VIII DE LA COAGULACION SANGUINEA HUMANO/FACTOR DE VON WILLEBRAND SOLUCION INYECTABLE 250 UI/600 UI ENVASE CON UN FRASCO AMPULA CON LIOFILIZADO Y UN FRASCO AMPULA CON 5 ML DE DILUYENTE",
"unit": "PIEZA",
"requested_quantity": "432",
"awarded_quantity": null,
"unit_price": "1575.89",
"subtotal": "680784.48",
"tax": "537.6",
"other_taxes": null,
"total": "680784.48"
}
]
},
{
"id": "C-2026-00003953",
"internal_reference": "IB/BMX/0039/2026",
"title": "COMPRA CONSOLIDADA DE MEDICAMENTOS PATENTE Y FUENTE ÚNICA: TERCER PROCEDIMIENTO",
"status": "CONFIRMADA",
"contractor": {
"name": "CSL BEHRING SA DE CV",
"normalized_name": "CSL BEHRING",
"rfc_type": null,
"slug": "csl-behring"
},
"contract_period": {
"published_at": "2026-01-15T20:39:51.000Z",
"starts_at": "2026-01-03T06:00:00.000Z",
"ends_at": "2026-12-31T06:00:00.000Z"
},
"value": {
"subtotal": "5178961.92",
"tax": "0",
"total": "5178961.92",
"maximum_subtotal": "12947404.8",
"maximum_total": "12947404.8",
"currency": "MXN"
},
"open_contract_type": null,
"quantity": null,
"exercised_quantity": null,
"participants": [],
"line_items": [
{
"number": "0",
"cucop_code": "25301-2717",
"description": "010.000.6055.00 INHIBIDOR DE LA ESTERASA C1 HUMANO SOLUCION INYECTABLE 500 UI ENVASE CON FRASCO AMPULA CON LIOFILIZADO Y FRASCO AMPULA CON 10 ML DE DILUYENTE",
"unit": "PIEZA",
"requested_quantity": "384",
"awarded_quantity": null,
"unit_price": "13486.88",
"subtotal": "5178961.92",
"tax": "302.72",
"other_taxes": null,
"total": "5178961.92"
}
]
}
],
"documents": [
{
"id": null,
"annex_number": 1,
"document_type": null,
"description": "ANEXO TÉCNICO",
"filename": "ANEXO 1A 2026.pdf",
"availability": "available",
"size_bytes": "28017456",
"mime_type": "application/pdf",
"sha256": null,
"uploaded_at": "2026-01-11T18:27:34.137Z",
"updated_at": "2026-01-11T18:27:34.139Z"
},
{
"id": null,
"annex_number": 1,
"document_type": null,
"description": "JUSTIFICACIÓN DE EXCEPCIÓN",
"filename": "JUSTI 1A 2026.pdf",
"availability": "available",
"size_bytes": "3119102",
"mime_type": "application/pdf",
"sha256": null,
"uploaded_at": "2026-01-11T18:27:36.165Z",
"updated_at": "2026-01-11T18:27:36.167Z"
},
{
"id": null,
"annex_number": 6,
"document_type": null,
"description": "OFICIO DE NOTIFICACIÓN DE ADJUDICACIÓN",
"filename": "AD CSL.pdf",
"availability": "available",
"size_bytes": "1560078",
"mime_type": "application/pdf",
"sha256": null,
"uploaded_at": "2026-01-11T18:27:38.113Z",
"updated_at": "2026-01-11T18:27:38.115Z"
}
],
"alternates": [],
"similar": [
{
"numero_procedimiento": "aa-12-nbg-012nbg003-i-311-2023",
"nombre_procedimiento": "RM-AF-0757/23",
"dependencia": "HIM",
"siglas": "HIM",
"score": 0.11429798603057861
},
{
"numero_procedimiento": "aa-12-nbg-012nbg003-i-84-2023",
"nombre_procedimiento": "MEDICINAS Y PRODUCTOS FARMACEUTICOS",
"dependencia": "HIM",
"siglas": "HIM",
"score": 0.11552815940808148
},
{
"numero_procedimiento": "aa-12-nef-012nef001-i-112-2025",
"nombre_procedimiento": "COMPRA CONSOLIDADA DE MEDICAMENTOS PATENTE Y FUENTE ÚNICA: TERCER PROCEDIMIENTO",
"dependencia": "BIRMEX",
"siglas": "BIRMEX",
"score": 0.11754900917702815
},
{
"numero_procedimiento": "aa-12-ncg-012ncg001-n-72-2023",
"nombre_procedimiento": "FACTOR VIII 1000 U.I. (WILATE) PRES. CAJA C/1 FCO.AMP.",
"dependencia": "INCMNSZ",
"siglas": "INCMNSZ",
"score": 0.12301743763789008
},
{
"numero_procedimiento": "aa-12-nbd-012nbd001-i-345-2023",
"nombre_procedimiento": "\"MEDICINAS Y PRODUCTOS FARMACEUTICOS\"",
"dependencia": "HGM",
"siglas": "HGM",
"score": 0.1284227967262268
},
{
"numero_procedimiento": "aa-73-019-914010985-i-15-2025",
"nombre_procedimiento": "ADQUISICIÓN DEL MEDICAMENTO CON CLAVE 010.000.6059.00 FACTOR VIII",
"dependencia": "SECRETARÍA DE SALUD (JAL)",
"siglas": "073019",
"score": 0.13345799247795287
}
]
}